Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2003
06/24/2003US6582694 Method for preparing a viral aerosol
06/24/2003US6582693 Recombinant MVA virus expressing the E2 gene of Bovine papillomavirus and its use in the therapy of tumors generated by papillomaviruses
06/24/2003US6582692 Recombinant adeno-associated virus virions for the treatment of lysosomal disorders
06/24/2003US6582691 Expression vector for the production of dead proteins
06/24/2003CA2223694C Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
06/24/2003CA2171544C Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains
06/24/2003CA2165566C Conotoxins having acetylcholin receptor binding properties
06/24/2003CA2047142C Skin test to human papillomavirus type 16
06/24/2003CA2012311C New protein-polycation-conjugate
06/24/2003CA1341433C Purification of interleukin 1
06/22/2003CA2412226A1 Compositions, methods and systems for discovery of lipopeptides
06/21/2003CA2365811A1 A new gene therapy using antisense strategy to estrogen receptors (er .alpha. and/or er .beta.) to optimize vascular healing and cardioprotection after vascular injury
06/19/2003WO2003050591A1 Multi-substrate biochip unit
06/19/2003WO2003050546A2 Resistance circuit stabilization and pulse duration control systems for electroporation instruments
06/19/2003WO2003050540A2 Flexible method and apparatus for high throughput production and purification of multiple proteins
06/19/2003WO2003050531A2 Method for displaying loops from immunoglobulin domains in different contexts
06/19/2003WO2003050504A2 Methods and compositions to treat cardiovascular disease usin g 1419, 58765 and 2201
06/19/2003WO2003050501A2 Indirect fluctuation screening
06/19/2003WO2003050312A1 Methods for determining transcriptional activity
06/19/2003WO2003050310A2 Methods for the identification of inhibitors of asparagine synthase, 5-aminolevulinate synthase, histidinol-phosphatase, 3-isopropylmalate and threonine synthase as antibiotics
06/19/2003WO2003050309A1 ANTISENSE MODULATION OF PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASE, Iα EXPRESSION
06/19/2003WO2003050308A1 Highly-sensitive genomic assays employing chimeric bacteriophage standards
06/19/2003WO2003050306A1 Hybridization portion control oligonucleotide and its uses
06/19/2003WO2003050305A1 Annealing control primer and its uses
06/19/2003WO2003050304A1 Annealing control primer system for regulating primer annealing specificity and its applications
06/19/2003WO2003050303A2 Biallelic markers of d-amino acid oxidase and uses thereof
06/19/2003WO2003050301A2 Susceptibility locus for schizophrenia
06/19/2003WO2003050296A2 Method for determining the activity of ornithine decarboxylase and for identifying effectors of ornithine decarboxylase activity
06/19/2003WO2003050288A1 Methods and means for gene silencing in plants
06/19/2003WO2003050287A2 Method for modifying plant morphology, biochemistry and physiology comprising expression of plant cytokinin oxidase
06/19/2003WO2003050285A1 Method for preparing antisense molecules by using bacteriophages with closed single stranded genome and novel antisense molecules produced thereby
06/19/2003WO2003050284A1 Human prostate cancer candidate protein 1
06/19/2003WO2003050283A2 A structure for presenting desired peptide sequences
06/19/2003WO2003050282A1 Mutated cyp2d6 genes
06/19/2003WO2003050281A2 Fragments of the human zn-alpha2-glycolprotein and their use in methods of treatment of obesity
06/19/2003WO2003050280A1 Regulation of human fatty acid binding protein
06/19/2003WO2003050279A1 Human tumor related gene in region of sub-band 3 of band 3 of zone 1 of human chromosome 17 and detection kit
06/19/2003WO2003050278A2 Stabilisation of double-stranded nucleic acids using proteins
06/19/2003WO2003050277A1 Process for producing biodegradable polyester
06/19/2003WO2003050269A2 HIGH RESOLUTION TYPING SYSTEM FOR PATHOGENIC $i(E. COLI)
06/19/2003WO2003050265A2 Compositions and methods for normalizing assays
06/19/2003WO2003050260A2 Streptavidin expressed gene fusions and methods of use thereof
06/19/2003WO2003050259A2 Nucleic acids related to plant retroelements
06/19/2003WO2003050258A2 Endogenous retrovirus polypeptides linked to oncogenic transformation
06/19/2003WO2003050255A2 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
06/19/2003WO2003050254A2 Novel chimeric tnf ligands
06/19/2003WO2003050253A2 Proteins associated with cell growth, differentiation, and death
06/19/2003WO2003050252A2 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use
06/19/2003WO2003050250A2 Chondrocyte precursors derived from human embryonic stem cells
06/19/2003WO2003050249A2 Islet cells from human embryonic stem cells
06/19/2003WO2003050247A2 Antisense modulation of mhc class ii transactivator expression
06/19/2003WO2003050246A2 Antisense modulation of nod1 expression
06/19/2003WO2003050244A2 Antisense modulation of g protein-coupled receptor etbr-lp-2 expression
06/19/2003WO2003050242A2 Dna amplification and sequencing using dna molecules generated by random fragmentation
06/19/2003WO2003050240A2 Expression system
06/19/2003WO2003050238A2 Receptor-targeted adenoviral vectors
06/19/2003WO2003050236A2 Human genes and gene expression products isolated from human prostate
06/19/2003WO2003050233A2 Gene promoters
06/19/2003WO2003050143A1 Detection and removal of lead using lead-binding proteins
06/19/2003WO2003050133A1 Antisense modulation of estrogen receptor beta expression
06/19/2003WO2003049832A1 Extraction and winterization of lipids from oilseed and microbial sources
06/19/2003WO2003049806A1 Automatic electroporation optimization system
06/19/2003WO2003049773A1 Methods for inhibiting ocular processes
06/19/2003WO2003049768A1 Selective anesthetic agents and methods of identifying the same
06/19/2003WO2003049766A2 Method of purifying hepatitis a virus particles and vaccine preparation
06/19/2003WO2003049764A1 Composition for viral preservation
06/19/2003WO2003049763A1 Composition for the preservation of viruses
06/19/2003WO2003049762A2 Immunisation against chlamydia trachomatis
06/19/2003WO2003049723A2 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity
06/19/2003WO2003049703A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
06/19/2003WO2003049691A2 Antisense modulation of pctaire protein kinase 1 expression
06/19/2003WO2003049686A2 Stabilization of hypoxia inducible factor (hif) alpha
06/19/2003WO2003049671A2 Functionalized materials and libraries thereof
06/19/2003WO2003049602A2 Diagnostic methods for protein profiling
06/19/2003WO2003049538A2 Methods for the cost-effective saccharification of lignocellulosic biomass
06/19/2003WO2003049537A1 Method of preparing eggs for nuclear transfer and uses thereof
06/19/2003WO2003049525A2 Methods and materials for the production of organic products in cells of $i(candida) species
06/19/2003WO2003035681A3 Mycobacterial genes down-regulated during latency
06/19/2003WO2003027252A3 Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods
06/19/2003WO2003016517A3 Kinase crystal structures
06/19/2003WO2003002714A3 Protein tyrosine phosphatase 2 gene disruptions, compositions and methods related thereto
06/19/2003WO2003000919A3 Method for detecting diseases caused by chromosomal imbalances
06/19/2003WO2002094864A3 Human cdnas and proteins and uses thereof
06/19/2003WO2002083846A9 Methods of analysis and labeling of protein-protein interactions
06/19/2003WO2002077237A3 Transporters and ion channels
06/19/2003WO2002077020A3 Virulence genes in h. influenzae
06/19/2003WO2002070755A3 Fen endonucleases
06/19/2003WO2002068584A3 Antisense modulation of cytohesin-1 expression
06/19/2003WO2002062847A3 Superficial zone protein and methods of making and using same
06/19/2003WO2002061087A3 Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides
06/19/2003WO2002057439A3 Plant transcription factors
06/19/2003WO2002057315A3 Streptococcal streptolysin s vaccines
06/19/2003WO2002048376A3 Bacterial host strains
06/19/2003WO2002048326A8 Human caplain proteins and polynucleotides coding therefor
06/19/2003WO2002044375A3 Compositions and methods for diagnosing or treating psoriasis
06/19/2003WO2002044342A9 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof
06/19/2003WO2002043660A3 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment
06/19/2003WO2002042499A3 Compositions and methods relating to prostate specific genes and proteins
06/19/2003WO2002042462A3 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
06/19/2003WO2002040503A3 Haplotypes of the plau gene
1 ... 2491 2492 2493 2494 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 2505 2506 2507 2508 2509 2510 2511 ... 4023